Xetra
16.04.26 | 17:35
150,24 Euro
-0,92 % -1,40
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 150,64 | 151,04 | 17:54 | |
| 150,58 | 151,08 | 17:54 |
► 16.04.: | | | | | | | | |
17:30
► 15.04.: | | | | | | | | |
► Aktueller BIOGEN Börsenkurs + Xetra-Orderbuch
► 15.04.: | | | | | | | | |
► Aktueller BIOGEN Börsenkurs + Xetra-Orderbuch
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 285,00 | 10 | |||
| 266,00 | 45 | |||
| 244,00 | 35 | |||
| 222,00 | 45 | |||
| 185,60 | 5 | |||
| 168,80 | 20 | |||
| 150,80 | 98 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/idp.htm [/URL] | ||||
| 98 | 149,94 | |||
| 57 | 149,86 | |||
| 57 | 149,78 | |||
| 57 | 145,48 | |||
| 40 | 1,234 | |||
| 1.063 | 0,000 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 1.372 | 0,188 | 258 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 17:19:16 | 150,50 | 7 |
| 16:57:20 | 150,00 | 18 |
| 15:13:06 | 152,36 | 72 |
| 13:53:32 | 150,60 | 2 |
| 13:30:53 | 152,40 | 38 |
| 13:03:41 | 152,28 | 36 |
| 11:41:33 | 152,28 | 35 |
| Tagesumsatz Xetra | -1,40 -0,92 % | 303 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Piper Sandler upgrades Biogen stock rating on acquisition strength | 14 | Investing.com | ||
| BIOGEN Aktie jetzt für 0€ handeln | |||||
| Di | Biogen raised to Overweight at Piper Sandler on Apellis buyout | 2 | Seeking Alpha | ||
| 09.04. | Biogen to acquire Apellis in $5.6bn deal | 17 | PMLiVE | ||
| 08.04. | Biogen settles investor lawsuit over its messaging on failed Alzheimer's drug Aduhelm | 2 | FiercePharma | ||
| 07.04. | Biogen-Übernahme treibt Apellis-Aktie auf neues Jahreshoch | 11 | Investing.com Deutsch |
1 2 3 4 5 Weiter >>
298 Nachrichten in den letzten 12 Monaten
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| 13:26 | Resverlogix Corp.: Resverlogix Corp. Announces Filing of Annual Filings and Revocation of MCTO | Newsfile | Calgary, Alberta--(Newsfile Corp. - April 16, 2026) - Resverlogix Corp. (TSX: RVX) ("Resverlogix" or the "Company") announces the revocation, effective April 15, 2026, of a management cease trade... ► Artikel lesen | |
| 13:26 | OS Therapies: OS Therapies Files New Patent Application Covering Biomarkers of the Immune Response to Listeria Monocytogenes | Newsfile | New patent application covers treatment-emergent immune signature related to 'turning cold tumors hot' and the activation of targeted cytotoxic cellular immune responses Company to host conference... ► Artikel lesen | |
| 13:22 | Tiziana Life Sciences Ltd.: Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function | GlobeNewswire (Europe) | Data from independent academic collaborators published on bioRxiv support the therapeutic potential of the Company's lead candidate, intranasal foralumab, for Long COVID associated "brain fog".BOSTON... ► Artikel lesen | |
| 13:06 | Alkermes plc: Alkermes to Present Additional Data From Vibrance-1 Phase 2 Study of Alixorexton in Patients with Narcolepsy Type 1 at the American Academy of Neurology (AAN) 2026 Annual Meeting | Business Wire | - Alixorexton Data From Seven-Week Open-Label Extension Period Demonstrated Sustained Improvements in Patient-Reported Disease Severity, Cognitive Functioning and Fatigue- - Alixorexton Was Generally... ► Artikel lesen | |
| 14:06 | Bio-Techne Corporation: Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity | PR Newswire | Bio-Techne introduces a streamlined brand architecture that organizes its technologies into three focused portfolio brands: R&D Systems, Bio-Techne Spatial, and Bio-Techne Diagnostics.The... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIOGEN INC finden Sie auf Wallstreet Online.